2-[(6'-fluoro-2'-oxo-spiro[cyclopropane-1,3'-indoline]-1'-yl)methyl]-1-(4,4,4-trifluorobutyl)benzimidazole-5-carboxamidine

ID: ALA4855358

PubChem CID: 164617986

Max Phase: Preclinical

Molecular Formula: C23H21F4N5O

Molecular Weight: 459.45

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)c1ccc2c(c1)nc(CN1C(=O)C3(CC3)c3ccc(F)cc31)n2CCCC(F)(F)F

Standard InChI:  InChI=1S/C23H21F4N5O/c24-14-3-4-15-18(11-14)32(21(33)22(15)7-8-22)12-19-30-16-10-13(20(28)29)2-5-17(16)31(19)9-1-6-23(25,26)27/h2-5,10-11H,1,6-9,12H2,(H3,28,29)

Standard InChI Key:  IUNZGXGVPQEGFJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    9.8914   -4.4707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3082   -5.1874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7205   -4.4682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8245   -8.0193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5409   -7.6058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5380   -6.7754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8227   -6.3662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1096   -7.6064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1063   -6.7821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3214   -6.5305    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8394   -7.1993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3267   -7.8642    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0144   -7.2027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5991   -6.4899    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9274   -5.7373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7742   -6.4094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6015   -5.6037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8189   -5.3521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2083   -5.9050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3856   -6.7129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1680   -6.9609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7331   -5.5599    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7764   -7.2692    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.0750   -8.6498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6295   -9.2607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3777  -10.0463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9323  -10.6571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6805  -11.4428    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.7385  -10.4823    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   13.5122  -11.2372    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.2510   -6.3602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9669   -6.7699    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2478   -5.5352    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  0
  1  3  1  0
  8  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  9  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15  2  1  0
  2 17  1  0
 16 14  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 15 22  2  0
 20 23  1  0
 12 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 27 30  1  0
  6 31  1  0
 31 32  1  0
 31 33  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4855358

    ---

Associated Targets(Human)

HEp-2 (3859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

F Fusion glycoprotein F0 (67 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human orthopneumovirus (392 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 459.45Molecular Weight (Monoisotopic): 459.1682AlogP: 4.38#Rotatable Bonds: 6
Polar Surface Area: 88.00Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.80CX LogP: 3.46CX LogD: 1.08
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.33Np Likeness Score: -1.21

References

1. Cockerill GS, Angell RM, Bedernjak A, Chuckowree I, Fraser I, Gascon-Simorte J, Gilman MSA, Good JAD, Harland R, Johnson SM, Ludes-Meyers JH, Littler E, Lumley J, Lunn G, Mathews N, McLellan JS, Paradowski M, Peeples ME, Scott C, Tait D, Taylor G, Thom M, Thomas E, Villalonga Barber C, Ward SE, Watterson D, Williams G, Young P, Powell K..  (2021)  Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus Fusion.,  64  (7.0): [PMID:33729773] [10.1021/acs.jmedchem.0c01882]

Source